Natco Pharma Fact Sheet, Natco Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Natco Pharma Fact Sheet    (NTPH)

Here is the latest financial fact sheet of Natco Pharma. For more details, see the Natco Pharma quarterly results and Natco Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

NATCO PHARMA Price History

Price Rs 575.3
Mkt Cap Rs m 95,586
Vol '000 0.3
P/E X 15.8
P/CF X 12.6
EPS (TTM) Rs 36.4
% ch % -0.1
No. of shares m 166.15
% ch week % 2.0
% ch 1-mth % 0.6
% ch 12-mth % -20.7
52 week H/L Rs 801.2/482.0
(As on Oct 23, 2019 11:05:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NATCO PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
NATCO PHARMA EQUITY SHARE DATA
High Rs8772,2916248491,080 
Low Rs424656366418671 
Sales per share (Unadj.) Rs223.4248.4327.8578.9592.1 
Earnings per share (Unadj.) Rs31.137.643.5138.9188.4 
Diluted earnings per shareRs6.27.59.129.241.8 
Cash flow per share (Unadj.) Rs40.351.858.2154.5206.3 
Dividends per share (Unadj.) Rs5.005.001.256.758.25 
Adj. dividends per shareRs1.001.000.261.421.83 
Dividend yield (eoy) %0.80.30.31.10.9 
Book value per share (Unadj.) Rs219.5254.6372.8473.8833.6 
Adj. book value per shareRs43.750.978.199.5185.1 
Shares outstanding (eoy) m33.0733.2334.8334.9036.90 
Bonus/Rights/Conversions  PA-ISISIS 
Price / Sales ratio x2.95.91.51.11.5 
Avg P/E ratio x20.939.211.44.64.6 
P/CF ratio (eoy) x16.128.48.54.14.2 
Price / Book Value ratio x3.05.81.31.31.1 
Dividend payout %16.113.32.94.94.4 
Avg Mkt Cap Rs m21,50448,96317,23022,11632,311 
No. of employees `000NA3.11.34.44.8 
Total wages/salary Rs m1,1281,3691,8672,4323,256 
Avg. sales/employee Rs ThNM2,647.78,462.64,579.94,522.5 
Avg. wages/employee Rs ThNM439.31,383.8551.3674.0 
Avg. net profit/employee Rs ThNM400.81,124.21,099.31,439.0 
NATCO PHARMA INCOME DATA
Net Sales Rs m7,3898,25311,41620,20221,848 
Other income Rs m167149108139404 
Total revenues Rs m7,5568,40211,52420,34122,252 
Gross profit Rs m1,7932,1002,6406,8349,284 
Depreciation Rs m304473510544662 
Interest Rs m366317229185154 
Profit before tax Rs m1,2901,4592,0096,2448,872 
Minority Interest Rs m46-44-1400 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m0-151000 
Tax Rs m309154791,3951,920 
Profit after tax Rs m1,0271,2491,5174,8496,952 
Gross profit margin %24.325.423.133.842.5 
Effective tax rate %23.91.023.922.321.6 
Net profit margin %13.915.113.324.031.8 
NATCO PHARMA BALANCE SHEET DATA
Current assets Rs m3,6814,8308,32310,87321,307 
Current liabilities Rs m3,1234,1374,9296,2655,920 
Net working cap to sales %7.68.429.722.870.4 
Current ratio x1.21.21.71.73.6 
Inventory Days Days89971146373 
Debtors Days Days59858486107 
Net fixed assets Rs m7,6858,3899,25311,69314,986 
Share capital Rs m331332348349369 
"Free" reserves Rs m6,6707,94512,37316,14430,353 
Net worth Rs m7,2598,46112,98316,53430,760 
Long term debt Rs m955970000 
Total assets Rs m11,95713,84018,23823,17637,151 
Interest coverage x4.55.69.834.858.6 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x0.60.60.60.90.6 
Return on assets %11.711.39.621.719.1 
Return on equity %14.214.811.729.322.6 
Return on capital %20.716.817.138.929.3 
Exports to sales %39.434.727.500 
Imports to sales %5.76.510.200 
Exports (fob) Rs m2,9082,8663,14100 
Imports (cif) Rs m4215381,16800 
Fx inflow Rs m3,4453,1563,4576,79310,322 
Fx outflow Rs m7039591,6882,2542,978 
Net fx Rs m2,7432,1971,7694,5387,343 
NATCO PHARMA CASH FLOW
From Operations Rs m 1,440 927 1,024 3,458 4,636 
From Investments Rs m -1,089 -1,148 -1,755 -2,994 -11,155 
From Financial Activity Rs m -353 291 856 -477 6,509 
Net Cashflow Rs m -1 22 117 -7 -18 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.0%
Foreign collaborators 1.5%
Indian inst/Mut Fund 7.8%
FIIs 16.6%
ADR/GDR 0.0%
Free float 26.0%
Shareholders 25,395
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF NATCO House, Road No.2, Banjara Hills, Hyderabad - 500 033
E-MAIL investors@natcopharma.co.in WEB www.natcopharma.co.in
TELEPHONE (040) 2354 7532 FAX (040) 2354 8243
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Venture Capital, 12-10-167, Bharatnagar, Hyderabad-500 018
AUDITOR Walker, Chandiok & Co.
CHM: V. C. Nannapaneni (MD) COMP SEC: M. Adinarayana YEAR OF INC: 1981 BSE CODE: 524816 FV (Rs): 10 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  FDC LTD.  

Compare NATCO PHARMA With:   GLENMARK PHARMA  ELDER PHARMA  AMAR REMEDIES  J.B.CHEMICALS  FDC LTD.  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Realty and Telecom Stocks Drag(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is flat while the Hang Seng is down 0.9%.

Views on news

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATCO PHARMA

NATCO PHARMA - TEVA PHARMA COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS